Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Merit Medical Systems, Inc. (MMSI) Presents at Bank of America Global Healthcare Conference 2026 Transcript
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Merit Medical Systems trades at 17-18x earnings with solid fundamentals, moderate leverage, and reasonable valuation, supporting an upbeat outlook. Q1 organic growth was on the lower end, but full-year guidance was maintained and even slightly raised for sales, reflecting recent M&A contributions. Growth engines include the View Point Medical acquisition and WRAPSODY, both expected to accelerate revenue and margin expansion into 2026.
Merit Medical Systems, Inc. (MMSI) Q1 2026 Earnings Call Transcript
Merit Medical (MMSI) came out with quarterly earnings of $0.94 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.86 per share a year ago.
MMSI rides strong cardiovascular demand, therapeutic growth and innovation push, but tariffs, China pressure and OEM weakness cloud its near-term outlook.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Merit Medical acquires View Point Medical for $140M, boosting tumor detection tech and expanding its oncology portfolio with advanced localization solutions.
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock?